Dr. Michael Cutler, DO
Cardiac Electrophysiology (Clinical Cardiac Electrophysiology Physician)
5169 S Cottonwood St, Ste 510
Murray, UT 84107
Who else practices at this address →
Salt Lake County includes primary care (36% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- University of North Texas Hsc, College of Osteopathic Med (2004)
- Years since graduation
- 22
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 1,016
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2004Medical school: University of North Texas Hsc, College of Osteopathic Med
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Clinical Cardiac Electrophysiology Physician primary
UT license 8830531-1204
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Intermountain Medical Center Murray, UT
- St. George Regional Hospital St George, UT
- Intermountain Health Riverton Hospital Riverton, UT
- Intermountain Health Alta View Hospital Sandy, UT
- Park City Hospital Park City, UT
Medical groups
- Ihc Health Services Inc (3,960 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,016
- Services billed
- 2,703
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 506 | 206 |
| Established patient office or other outpatient visit, 20-29 minutes | 373 | 300 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 373 | 329 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 343 | 147 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 278 | 242 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 167 | 63 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 114 | 113 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 106 | 105 |
| Established patient office or other outpatient visit, 30-39 minutes | 73 | 68 |
| New patient office or other outpatient visit, 45-59 minutes | 65 | 65 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Eliquis (apixaban) Other prescribers in Murray, UT | 529 |
| Flecainide Acetate Other prescribers in Murray, UT | 405 |
| Metoprolol Succinate Other prescribers in Murray, UT | 285 |
| Xarelto (rivaroxaban) Other prescribers in Murray, UT | 98 |
| Diltiazem 24hr Er (Cd) (diltiazem hcl) Other prescribers in Murray, UT | 85 |
| Amiodarone Hcl Other prescribers in Murray, UT | 80 |
| Pantoprazole Sodium Other prescribers in Murray, UT | 51 |
| Dofetilide | 28 |
| Sotalol (sotalol hcl) Other prescribers in Murray, UT | 27 |
| Dabigatran Etexilate (dabigatran etexilate mesylate) Other prescribers in Murray, UT | 26 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 4 companies reported 13 payments worth $7,954 in total to this clinician.
| Boston Scientific Corporation | $5,320 |
|---|---|
| Altathera Pharmaceuticals LLC | $1,997 |
| Biosense Webster, Inc. | $387 |
| Medtronic, Inc. | $250 |
| Consulting Fee | $6,875 |
|---|---|
| Food and Beverage | $1,079 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Boston Scientific Corporation Oct 23, 2025 | Consulting Fee General - Therapies · General - Therapies_EP | $5,000 |
| Altathera Pharmaceuticals LLC Apr 29, 2025 | Consulting Fee Sotalol Hydrochloride · Cardiovascular | $1,875 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 4 industry-funded studies in 2025, from 4 companies. The companies reported $145,759 in research payments for these studies, mostly to the institutions running them.
- Pulsed Field Ablation (PFA) vs Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation
Boston Scientific Corporation · Active, not recruiting · NCT06096337 - Assessment of Safety and Effectiveness in Treatment Management of Atrial Fibrillation with the BWI PFA Pulsed Field Ablation (PFA) System with OMNYPULSE Catheter
Biosense Webster, Inc. - HEAL-IST IDE Trial
Atricure, Inc. · Active, not recruiting · NCT05280093 - A Randomized, Placebo-controlled, Participant- and Investigator-blinded Study to Evaluate the Efficacy in Reducing Atrial Fibrillation Burden (AFB) as Well as the Safety, Tolerability, and Pharmacokinetics of Oral PKN…
Novartis Pharmaceuticals Corporation
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.